0001209191-21-022485.txt : 20210322
0001209191-21-022485.hdr.sgml : 20210322
20210322214757
ACCESSION NUMBER: 0001209191-21-022485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210322
FILED AS OF DATE: 20210322
DATE AS OF CHANGE: 20210322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pauls Matthew
CENTRAL INDEX KEY: 0001573429
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 21762961
MAIL ADDRESS:
STREET 1: 9 DEER PARK DRIVE
STREET 2: SUITE C
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 512-614-1848
MAIL ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-22
0
0001160308
Savara Inc
SVRA
0001573429
Pauls Matthew
6836 BEE CAVE ROAD
BUILDING III, SUITE 200
AUSTIN
TX
78746
1
1
0
0
CHIEF EXECUTIVE OFFICER
Common Stock
2021-03-22
4
P
0
24100
2.0721
A
280722
D
The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
The price is a weighted average purchase price. The purchase prices ranged from $2.04 to $2.11. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
/s/ Kathleen R. McCabe as attorney-in-fact for Matthew Pauls
2021-03-22